A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Clinical trial NCT06632600 · RECRUITING
Trial details
- NCT number
- NCT06632600
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2027-07-22
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.